Mastercard stock price falls ahead of earnings week as JPMorgan calls consumer “healthy”

Mastercard stock price falls ahead of earnings week as JPMorgan calls consumer “healthy”

New York, January 25, 2026, 10:35 AM EST — Market closed.

Mastercard Incorporated (MA) shares dipped 1.52% to close at $524.74 on Friday, wrapping up the week on a weaker note before a busy slate of events hits the payments and financial sectors. (Mastercard)

Why it matters now: Mastercard’s earnings and guidance come at a time when investors lean on card networks for a quick gauge of holiday-quarter spending, travel demand, and pricing power. With a slew of major earnings and a Federal Reserve decision lined up this week, rate expectations could swing sharply—rippling through the entire payments sector.

JPMorgan’s Tien-tsin Huang sees just a modest dip in Q4 spending. He noted the domestic consumer is still in good shape. Huang put Mastercard’s revenue forecast at roughly $8.72 billion, with earnings per share coming in at $4.20. (Benzinga)

Friday’s decline happened amid a heavier-than-normal trading volume, around 5 million shares changing hands. The Dow closed lower, and Visa’s stock saw little movement in an otherwise mixed session. Mastercard’s shares still sit about 13% below their 52-week peak reached back in August. (MarketWatch)

Mastercard plans to report its fourth-quarter and full-year 2025 earnings on Thursday, Jan. 29, with a conference call scheduled for 9:00 a.m. Eastern. (Mastercard)

Investors are keenly watching for updates on cross-border volume — card spending outside a cardholder’s home country — and whether new services and pricing remain strong if U.S. growth slows. Changes in expense patterns could prove just as critical as the headline profit.

The Federal Reserve’s two-day meeting wraps up on Jan. 28, with the policy announcement scheduled for 2:00 p.m. Eastern. Chair Jerome Powell is expected to speak shortly after, at 2:30 p.m. (Federal Reserve)

After the Fed’s decision, Tuesday brings U.S. consumer confidence data, with trade figures and weekly jobless claims set for later in the week. Earnings reports from Visa and American Express also loom. (Investopedia)

But one risk investors haven’t ignored is Washington. The Credit Card Competition Act, in one form, aims to limit routing restrictions that lock transactions to a single network. If it takes hold, it could boost competition among networks and put pressure on fees. (Congress)

Monday’s open is straightforward: Wednesday’s Fed signals might shake things up, while Thursday’s Mastercard report will put spending to the test against its premium valuation. The key will be the guidance, which should drive the next move.

Stock Market Today

  • Novo Nordisk Shares Seen as Undervalued Despite 27.8% Drop Over Past Year
    January 25, 2026, 10:48 AM EST. Novo Nordisk's (NYSE:NVO) stock has declined 27.8% over the past year but gained 18.8% in the last month. Despite this, a discounted cash flow (DCF) model estimates an intrinsic value of $149.81 per share, suggesting shares trade at a 58.4% discount to fair value. Novo Nordisk scored 5 out of 6 on Simply Wall St's valuation framework, indicating undervaluation on most metrics. Analysts forecast free cash flow growth through 2030, supporting bullish long-term prospects. The recent mixed return profile and ongoing interest as a leading pharma firm frame current investor debates on valuation and risks. Novo Nordisk remains a key biotech name under close watch for potential upside against recent price weakness.
ASML stock price: what investors watch ahead of the Jan. 28 results
Previous Story

ASML stock price: what investors watch ahead of the Jan. 28 results

Go toTop